Local removal of phagocytic synovial lining cells by clodronate- liposomes decreases cartilage destruction during collagen type II arthritis

Annals of the Rheumatic Diseases

Volumn 57, Issue 7, 1998, Pages 408-413

  Van Lent, P L E M ^a   Holthuysen, A E M ^a   Van Rooijen, N ^b   Van De Putte, L B A ^a   Van Den Berg, W B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLODRONIC ACID; DEXAMETHASONE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CARTILAGE DEGENERATION; CELL DESTRUCTION; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; INTRAARTICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYNOVIOCYTE;

EID: 0031818876     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.7.408     Document Type: Article

References (33)

1. Harris ED. Pathogenesis of rheumatoid arthritis: a disorder associated with disfunctional immunoregulation. In:Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: basic principles and clinical correlates. New York: Raven Press, 1988:751-73.
2. Van Lent PLEM, Van den Hoek AEM, Van den Bersselaar LAM, Sparijaards MFR, van Rooijen N, Dijstra CD, et al. In vivo role of phagocytic lining cells in onset of experimental arthritis. Am J Pathol 1993;143:1226-37.
3. Van Lent PLEM, Holthuysen AEM, van den Bersselaar L, van Rooijen N, Joosten LAB, van de Loo FAJ, et al. Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis. Arthritis Rheum 1996;39:1545-55.
4. Van Lent PLEM, van de Hoek A, van den Bersselaar L, Dijkstra CD, van Rooijen N, van den Berg WB. Role of synovial macrophages in experimental arthritis. Res Immunol 1992;143:229-34.
5. Okada Y, Takeuchi N, Gonoji Y, Nakanishi I, Nagase H, Hayakawa T. Simultaneous production of collagenase, matrix metalloproteinase 3(stromelysin) and tissue inhibitor of metalloproteinases by rheumatoid synovial lining cells. Matrix Suppl 1992;1:398-9.
6. Maeda S, Sawai T, Uzuki M, Takahashi Y, Omoto H, Seki M, et al. Determination of interstitial collagenase(MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54:970-5.
7. Nawrocki B, Polette M, Clavel C, Morrone A, Eschard JP, Etienne JC, et al. Expression of stromelysin 3 and tissue inhibitors of matrix metalloproteinases, TIMP-1 and TIMP-2, in rheumatoid arthritis. Pathol Res Pract 1994;190:690-6.
8. Keyszer GM, Heer AH, Kriegsmann J, Geiler T, Trabandt A, Keysser M, et al. Comparative analysis of cathepsin L,cathepsin D and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization. Arthritis Rheum 1995;38:976-84.
9. Zvaifler NJ. Macrophages and the synovial lining. Scand J Rheumatol 1995;24 (suppl 101):67-75.
10. Van Lent PLEM, Van den Bersselaar L, Van den Hoek AEM, van de Ende M, Dijkstra CD, van Rooijen N, et al. Reversible depletion of synovial lining cells after intraarticular treatment with liposome encapsulated dichloromethylene diphosphonate. Rheumatol Int 1993;13:21-30.
11. Van Rooijen N, Sanders A, van den Berg TK. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propadimme. J Immunol Methods 1996;193:93-9.
12. Smith-Weber CB, Rittig M, Buchner E, Hauser I, Schmidt I, Palombo-Kinne E, et al. Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes. J Leukoc Biol 1996;60:230-44.
13. Trentham DE, Townes AS, Kang AH. Autoimmumty to collagen type II collagen: an experimental model of arthritis. J Exp Med 1977;146:857-68.
14. Stuart JM, Cremer MA, Kang AH, Townes AS. Collagen-induced arthritis in rats. Evaluation of early immunological events. Arthritis Rheum 1979;22:1344-51.
15. Caccese RG, Zimmerman JL, Carlson RP. Bacterial lipopolysaccharide potentiates type II collagen-induced arthritis in mice. Mediators of Inflammation 1992;1: 273-9.
16. Joosten LAB, Helsen MMA, van den Berg WB. Accelerated onset of collagen-induced arthritis by remote inflammation. Clin Exp Immunol 1994;97:204-11.
17. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.
18. Van den Berg WB, Van de Putte LBA, Zwarts WA, Joosten LAB. Electrical charge of the antigen determines intrarticular antigen handling and chronicity of arthritis in mice. J Clin Invest 1984;74:1850-9.
19. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87-94.
20. Wright CD, Muisch A, Busse R, Oswald H. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989;160:813-19.
21. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995;146: 75-85.
22. 4 labelled material from the tissue. J Clin Invest 1976;57:615-24.
23. Schalkwijk J, Van den Berg WB, Van de Putte LBA, Joosten LA. Elastase secreted by activated polymorphonuclear leucocytes causes chondrocyte damage and matrix degradation in intact articular cartilage:escape from in activation by alpha-1-proteinase inhibitor. Br J Exp Pathol 1987;68: 81-8.
24. Kleiner DE Jr, Stetler-Stevenson G. Structural biochemistry and activation of matrix metalloproteinasen. Curr Biol 1993;5:891-7.
25. Van Lent PLEM, Blom A, Holthuysen AEM, Jacobs CWM, van de Putte LBA, van den Berg WB. Monocytes macrophages rather than PMN are involved in early cartilage degradation in cationic immune complex arthritis in mice. J Leukoc Biol 1997;61:267-78.
26. Henderson B, Blake S. Connective tissue destruction in rheumatoid arthritis: therapeutic potential of selective metalloproteinase inhibitors. Immunopharmacology of joints and connective tissue. London: Academic Press, 1994:199-223.
27. Lohmander S, Nearne PJ, Sandy JD. The structure of aggrecan fragments in human synovial fluid: Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury and osteoarthritis. Arthritis Rheum 1993;36:1214-22.
28. MacNaul KL, Chartrain N, Lark M, Tocli MJ, Hutchinson NI. Discoordinate expression of stromelysin, collagenase and TIMP in human rheumatoid synovial fibroblasts: synergistic effects of IL-1 and TNF on stromelysine expression. J Biol Chem 1990;265:17238-45.
29. Pelletier JP, DiBattista JA, Roughly P, McCollum R, Martel-Pelletier J. Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 1993;19:545-68.
30. Janusz MJ, Hare M. Cartilage degradation by cocultures of transformed macrophage and fibroblast cell lines: a model of metalloproteinase-mediated connective tissue degradation. J Immunol 1993;150:1922-31.
31. Frisch SM, Ruley HE. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 1987;262:16300-4.
32. Hubbard JR, Mattmueller DR, Steinberg JJ, Poppas DP, Sledge CB. Effect of steroid hormones on endotoxin-mediated cartilage. Mol Cell Biochem 1988;79:31-7.
33. Jafari HS, Saez-Llorens X, Paris M, Rinderknecht S, Friedland I, Ehren S, et al. Dexamethasone attenuation of cytokine-mediated articular cartilage degradation in experimental lapine haemophilus arthritis. J Infect Dis 1993, 168:1186-93.